Pro-Dex, Inc. (PDEX)
NASDAQHealth CareMedical - Instruments & SuppliesSnapshot 2026-09-04
$73.41+18.88%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - Instruments & SuppliesSnapshot 2026-09-04
QuarterlyIQ Insights · PDEX
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | FY 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | Jun 2015 | Jun 2014 | Jun 2013 | Jun 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | 77.5 | 77.5 | 66.6 | 53.8 | 46.1 | 42.0 | 38.0 | 34.8 | 27.2 | 22.5 | 21.9 | 20.2 | 13.4 | 10.8 | 0.7 | 17.3 |
| Total Revenues | 77.5 | 77.5 | 66.6 | 53.8 | 46.1 | 42.0 | 38.0 | 34.8 | 27.2 | 22.5 | 21.9 | 20.2 | 13.4 | 10.8 | 0.7 | 17.3 |
| Cost of Revenues | 53.2 | 53.2 | 47.1 | 39.3 | 33.3 | 28.9 | 24.5 | 21.7 | 17.4 | 14.5 | 14.8 | 14.3 | 9.7 | 7.8 | 8.5 | 11.8 |
| Gross Profit | 24.3 | 24.3 | 19.5 | 14.6 | 12.7 | 13.1 | 13.6 | 13.1 | 9.8 | 7.9 | 7.2 | 4.9 | 3.7 | 3.0 | — | 5.4 |
| Operating Expenses & Income | ||||||||||||||||
| Selling, General & Admin | — | 8.0 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| R&D Expenses | 3.3 | 3.3 | 3.6 | 3.2 | 2.8 | 3.0 | 4.4 | 2.3 | 1.9 | 1.9 | 1.2 | 1.2 | 1.7 | 1.5 | 1.8 | 2.1 |
| Operating Income | 13.0 | 13.0 | 10.7 | 7.2 | 5.8 | 5.1 | 4.5 | 7.1 | 5.0 | 2.4 | 2.7 | 0.8 | (0.9) | (0.8) | (1.9) | (1.4) |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | 0.8 | 0.8 | 0.6 | 0.5 | 0.5 | 0.4 | 0.2 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | (0.0) |
| Interest & Investment Income | — | — | — | — | — | — | — | — | — | — | — | 0.0 | 0.0 | — | — | — |
| Net Interest Expenses | — | — | — | — | — | — | — | — | — | — | — | 0.0 | 0.0 | — | — | — |
| Other Non-Operating Income / Expenses | — | 5.0 | 1.4 | (4.5) | 3.7 | 0.6 | 3.1 | 0.8 | 0.4 | 0.2 | 0.0 | 0.3 | 0.5 | 0.1 | (0.0) | (0.0) |
| Asset Writedown | — | — | — | — | — | — | — | — | 1.0 | 1.0 | — | — | — | — | — | — |
| EBT, Incl. Unusual Items | 18.0 | 18.0 | 12.1 | 2.6 | 9.4 | 5.7 | 7.6 | 7.9 | 5.4 | 2.6 | 2.8 | 1.1 | (0.4) | (0.8) | (1.9) | (1.4) |
| Income Tax Expense | 4.4 | 4.4 | 3.1 | 0.5 | 2.4 | 1.1 | 1.4 | 1.8 | 1.3 | 1.0 | (2.1) | 0.0 | (0.0) | (0.1) | (0.0) | (0.4) |
| Earnings from Continuing Operations | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | (1.0) |
| Net Income | ||||||||||||||||
| Net Income | 13.7 | 13.7 | 9.0 | 2.1 | 7.1 | 4.6 | 6.2 | 6.1 | 4.1 | 1.6 | 5.1 | 0.8 | (0.4) | (0.5) | (1.8) | (0.9) |
| Per Share | ||||||||||||||||
| Basic EPS | — | 4.24 | 2.73 | 0.61 | 1.98 | 1.26 | 1.63 | 1.56 | 0.99 | 0.38 | 1.26 | 0.20 | — | — | — | (0.27) |
| Diluted EPS | — | 4.12 | 2.67 | 0.60 | 1.95 | 1.21 | 1.57 | 1.50 | 0.97 | 0.37 | 1.25 | 0.20 | — | — | — | (0.27) |
| Basic Weighted Avg Shares | — | 3.2 | 3.3 | 3.5 | 3.6 | 3.6 | 3.8 | 3.9 | 4.2 | 4.3 | 4.0 | 4.1 | — | — | 3.3 | 3.3 |
| Diluted Weighted Avg Shares | — | 3.3 | 3.4 | 3.6 | 3.6 | 3.8 | 3.9 | 4.1 | 4.3 | 4.3 | 4.1 | 4.2 | — | — | — | 3.3 |
| Supplemental | ||||||||||||||||
| EBITDA | — | 14.4 | 11.9 | 8.3 | 6.6 | 5.8 | 5.2 | 7.6 | 5.4 | 2.9 | 3.3 | 1.4 | (0.3) | (0.3) | (1.3) | (0.7) |
| EBIT | 13.0 | 13.0 | 10.7 | 7.2 | 5.8 | 5.1 | 4.5 | 7.1 | 5.0 | 2.4 | 2.7 | 0.8 | (0.9) | (0.8) | (1.9) | (1.4) |
| Effective Tax Rate | 24.2% | — | — | — | 25.0% | 19.7% | 19.0% | 22.7% | 23.8% | 37.9% | -75.9% | 2.2% | 9.9% | 13.8% | 2.0% | 31.5% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.